News Pfizer finally decides not to split up company Company will remain as one, but Read keeps his options open
News Unjustified price rises will stop, promises Allergan chief Says 'outlier' companies have 'violated' social contract
Views & Analysis The biggest pharma stories of 2016 so far The top 10 pharma milestones of the year to date.
News Lilly bags FDA okay for Wegovy pill rival orforglipron Eli Lilly has claimed US approval for oral GLP-1 agonist orforglipron, setting up a market clash with Novo Nordisk's first-to-market Wegovy pill.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
